Literature DB >> 194650

Evolution of poliovirus since introduction of attenuated vaccine.

Y E Cossart.   

Abstract

Genetic marker tests were performed on 997 strains of poliovirus isolated from patients with neurological disease and from healthy people in England and Wales. Before the introduction of live attenuated vaccine most strains could multiply at raised temperatures. Now, however, many strains isolated from cases of poliomyelitis or from healthy persons with no known contact with vaccine cannot grow above 37 degrees C, and in this respect resemble the vaccine strains. The three serotypes are also much more evenly represented. Hence probably to a limited extent the vaccine-like strains have established themselves in the community.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 194650      PMCID: PMC1607745          DOI: 10.1136/bmj.1.6077.1621

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  3 in total

1.  Antigenic analysis of polioviruses by kinetic studies of serum neutralization.

Authors:  W D McBRIDE
Journal:  Virology       Date:  1959-01       Impact factor: 3.616

2.  Genetic marker studies of poliovirus. I. Natural variation.

Authors:  Y E Cossart
Journal:  J Hyg (Lond)       Date:  1967-03

3.  A survey of enteroviruses and adenoviruses in the faeces of normal children aged 0-4 years. A report of the Public Health Laboratory Service and the Society of Medical Officers of Health.

Authors:  N S Galbraith
Journal:  J Hyg (Lond)       Date:  1965-12
  3 in total
  12 in total

1.  Isolation of viruses from sewage, with special regard to poliovirus: an evaluation of the sensitivity of three tissue culture methods.

Authors:  M Böttiger
Journal:  Bull World Health Organ       Date:  1978       Impact factor: 9.408

2.  Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine.

Authors:  G D Westrop; K A Wareham; D M Evans; G Dunn; P D Minor; D I Magrath; F Taffs; S Marsden; M A Skinner; G C Schild
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

3.  Smallpox ten years gone: what next?

Authors:  N D Noah; N T Begg
Journal:  Br Med J (Clin Res Ed)       Date:  1987-10-24

4.  Reversion to neurovirulence of the live-attenuated Sabin type 3 oral poliovirus vaccine.

Authors:  A J Cann; G Stanway; P J Hughes; P D Minor; D M Evans; G C Schild; J W Almond
Journal:  Nucleic Acids Res       Date:  1984-10-25       Impact factor: 16.971

5.  Molecular cloning of the genomes of poliovirus type 3 strains by the cDNA: RNA hybrid method.

Authors:  G Stanway; R C Mountford; S D Cox; G C Schild; P D Minor; J W Almond
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

6.  The nucleotide sequence of poliovirus type 3 leon 12 a1b: comparison with poliovirus type 1.

Authors:  G Stanway; A J Cann; R Hauptmann; P Hughes; L D Clarke; R C Mountford; P D Minor; G C Schild; J W Almond
Journal:  Nucleic Acids Res       Date:  1983-08-25       Impact factor: 16.971

7.  Fetal damage after accidental polio vaccination of an immune mother.

Authors:  A E Burton; E T Robinson; W F Harper; E J Bell; J F Boyd
Journal:  J R Coll Gen Pract       Date:  1984-07

8.  Comparison of the complete nucleotide sequences of the genomes of the neurovirulent poliovirus P3/Leon/37 and its attenuated Sabin vaccine derivative P3/Leon 12a1b.

Authors:  G Stanway; P J Hughes; R C Mountford; P Reeve; P D Minor; G C Schild; J W Almond
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

9.  Poliovirus type 3: molecular cloning of the genome and nucleotide sequence of the region encoding the protease and polymerase proteins.

Authors:  A J Cann; G Stanway; R Hauptmann; P D Minor; G C Schild; L D Clarke; R C Mountford; J W Almond
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

10.  Polio immunization policy in the United States: a new challenge for a new generation.

Authors:  D Salk
Journal:  Am J Public Health       Date:  1988-03       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.